EP1928247A4 - Composition et utilisation de phyto-percolate pour le traitement d'une maladie - Google Patents

Composition et utilisation de phyto-percolate pour le traitement d'une maladie

Info

Publication number
EP1928247A4
EP1928247A4 EP06758513A EP06758513A EP1928247A4 EP 1928247 A4 EP1928247 A4 EP 1928247A4 EP 06758513 A EP06758513 A EP 06758513A EP 06758513 A EP06758513 A EP 06758513A EP 1928247 A4 EP1928247 A4 EP 1928247A4
Authority
EP
European Patent Office
Prior art keywords
phyto
percolate
disease
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06758513A
Other languages
German (de)
English (en)
Other versions
EP1928247A2 (fr
Inventor
Tiffany Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Enhancement Products Inc
Original Assignee
Health Enhancement Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/013375 external-priority patent/WO2005112987A2/fr
Application filed by Health Enhancement Products Inc filed Critical Health Enhancement Products Inc
Publication of EP1928247A2 publication Critical patent/EP1928247A2/fr
Publication of EP1928247A4 publication Critical patent/EP1928247A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
EP06758513A 2005-04-20 2006-04-20 Composition et utilisation de phyto-percolate pour le traitement d'une maladie Withdrawn EP1928247A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2005/013375 WO2005112987A2 (fr) 2004-04-23 2005-04-20 Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie
US71902505P 2005-09-21 2005-09-21
US74177405P 2005-12-02 2005-12-02
PCT/US2006/015302 WO2006113925A2 (fr) 2005-04-20 2006-04-20 Composition et utilisation de phyto-percolate pour le traitement d'une maladie

Publications (2)

Publication Number Publication Date
EP1928247A2 EP1928247A2 (fr) 2008-06-11
EP1928247A4 true EP1928247A4 (fr) 2009-10-28

Family

ID=37115978

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06758513A Withdrawn EP1928247A4 (fr) 2005-04-20 2006-04-20 Composition et utilisation de phyto-percolate pour le traitement d'une maladie

Country Status (2)

Country Link
EP (1) EP1928247A4 (fr)
WO (1) WO2006113925A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807622B2 (en) 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US8586053B2 (en) 2005-09-21 2013-11-19 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
WO2008040516A2 (fr) * 2006-10-02 2008-04-10 Georg Fritzmeier Gmbh & Co. Kg Composition microbiologique et son utilisation
CA2827401A1 (fr) 2010-02-22 2011-08-25 Health Enhancement Products, Inc. Agents et mecanismes de traitement de l'hypercholesterolemie
US10232028B2 (en) 2013-06-13 2019-03-19 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
WO2016133922A1 (fr) 2015-02-16 2016-08-25 Zivo Bioscience, Inc. Procédés de modulation de réponses immunitaires et inflammatoires par le biais de l'administration d'une biomasse algale
MX2018009819A (es) 2016-02-16 2019-02-20 Zivo Bioscience Inc Soporte nutricional para animales mediante la administracion de un suplemento derivado de algas.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112987A2 (fr) * 2004-04-23 2005-12-01 Health Enhancement Products, Inc. Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
EP1212093B1 (fr) * 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Utilisation d'huile d'emeu et de ses diverses fractions comme excipient pour des medicaments et des preparations antifongiques, antibacteriennes et antivirales

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112987A2 (fr) * 2004-04-23 2005-12-01 Health Enhancement Products, Inc. Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Research indicates ProAlgaZyme may decrease risk of stroke or heart attack", INTERNET CITATION, 20 January 2004 (2004-01-20), XP002538927 *
"Western Glory Hole Inc. enters definitive agreement with Health Enhancement Products Inc", INTERNET CITATION, 30 October 2003 (2003-10-30), XP002538928 *
NODA KIYOSHI ET AL: "A water-soluble antitumor glycoprotein from Chlorella vulgaris", PLANTA MEDICA, THIEME, STUTTGART, DE, vol. 62, no. 5, 1 January 1996 (1996-01-01), pages 423 - 426, XP009120719, ISSN: 0032-0943 *
OBEN JULIUS ET AL: "The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health", LIPIDS IN HEALTH AND DISEASE, BIOMED CENTRAL, LONDON, GB, vol. 6, no. 1, 5 September 2007 (2007-09-05), pages 20, XP021029930, ISSN: 1476-511X *
See also references of WO2006113925A2 *
WONKEUK KIM ET AL: "Purification and Characterization of a Fibrinolytic Enzyme Produced from Bacillus sp. strain CK 11-4 Screened from Chungkook-Jang", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 62, no. 7, 1 July 1996 (1996-07-01), pages 2482 - 2488, XP007908743, ISSN: 0099-2240 *

Also Published As

Publication number Publication date
WO2006113925A3 (fr) 2007-06-14
WO2006113925A2 (fr) 2006-10-26
EP1928247A2 (fr) 2008-06-11

Similar Documents

Publication Publication Date Title
EP2007385A4 (fr) Composition cardiovasculaire et utilisation de ladite composition pour le traitement de la maladie d'alzheimer
EP1928453A4 (fr) Procedes et compositions permettant de prevenir et de traiter les maladies renales
IL186616A (en) Spyro-oxa-indoles and their use as drugs
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
EP1968607A4 (fr) Traitement du cancer et d'autres maladies
EP1931390A4 (fr) Compositions et methodes de traitement de maladies auto-immunes
EP1954800A4 (fr) Composition et utilisation d'un phyto-percolate pour le traitement d'une maladie
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
EP2063859A4 (fr) Composition cosmétique pour le traitement de la peau et procédés correspondants
EP1928247A4 (fr) Composition et utilisation de phyto-percolate pour le traitement d'une maladie
ZA200607471B (en) Materials and methods for treatment of allergic disease
IL187405A0 (en) Methods and compositions for the treatment of pain
EP1933853A4 (fr) Traitement de l'interruption de tissu et composition à employer dans ce traitement
EP1930017A4 (fr) Composition efficace pour la prévention et le traitement d une pathologie chez l adulte
EP2010215A4 (fr) Utilisations et compositions pour le traitement de la maladie de crohn
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
EP2007790A4 (fr) Composes et procedes destines au traitement de la douleur
HU0500145D0 (en) Composition for the treatment of oral diseases
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1865952A4 (fr) Compositions contenant des histamines pour le traitement des allergies
GB0504657D0 (en) Compositions and methods of treatment
EP1797430A4 (fr) Methodes et compositions de diagnostic et de traitement du cancer
EP1962882A4 (fr) Préparations et méthodes pour le traitement du diabète
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1850827A4 (fr) Composition pour traiter et prevenir la parodontopathie et son procede d'utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080320

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HEALTH ENHANCEMENT PRODUCTS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20090924

17Q First examination report despatched

Effective date: 20091120

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20141101